Infiniplex

Infiniplex Overview

Infiniplex's mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at an accessible and affordable cost. The company's goal is to identify common and rare cancer types through a standard, inexpensive blood test that could be carried out as part of routine checkups, leveraging existing laboratory equipment and know-how. Infiniplex aims to include tumor genomic testing as part of people's standard blood test checkups.

Cumulative Funding Raised Over Time ($)

Latest News

May 31, 2022 · chiportal.co.il

growth-positive

קרן טרה ונצ'ר פרטנרס ביצעה 3 השקעות בחברות סטארט-אפ חדשות בהיקף כולל של כ 3 מיליון דולר - Chiportal

Terra Venture Partners, a venture capital firm focusing on impact investments, has recently invested over $3 million in three Israeli startups - ViewNetic, Cognishape, and Infiniplex. These companies are developing solutions in the fields of artificial intelligence, healthcare, and agriculture. ViewNetic is developing an AI-based product to help monitor and identify pests and diseases in greenhouses. Cognishape is developing a digital drug to slow down cognitive decline in older adults. Infiniplex is developing a technology that allows for early detection of cancerous growths.

Investment

Funding

Team Members

7

Employees: 11-50

Web & Social Links

Locations

Yokne'am Illit, Israel

Photos & Videos

No files yet

Infiniplex Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info